Research concerning the CD40 ligand demonstrated its commitment to the development of the inflammatory process in various diseases, including cardiovascular diseases and atherosclerosis [12], as well as inflammatory bowel diseases such as colitis ulcerosa or Crohn’s disease [41]. This evidence concerns the gene CD40LG and atherosclerosis.